BSE filing, NSE: KFINTECH. Summary written from the filing by ALFA Finder's alert engine.
KFIN Technologies Ltd: key numbers
- Share price
- ₹855.00
- Market cap
- ₹14,781 Cr
- Revenue (annual)
- ₹1,301 Cr
- Net profit (annual)
- ₹343.7 Cr
- P/E (TTM)
- 42.4×Sector 19.7×
- Promoter holding
- 14.06%-8.76% QoQ
- FII holding
- 20.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KFIN Technologies Ltd
All →KFIN Technologies Earnings Call Transcript: Key Takeaways
Kfin reports consistent growth across all business lines despite challenging market macros.
- Call
- Guides 20% growth
KFIN Technologies Regulatory Approval
KFin Technologies' Thai subsidiary received a Foreign Business License from Thailand's Ministry of Commerce. The license enables the subsidiary to conduct permitted business activities under local law.
KFIN Technologies Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹4,018 mn, +29.9% y-o-y; EBITDA ₹1,610 mn (40.1% margin); PAT ₹1,003 mn, +7.5% y-o-y. Ascent-led international growth.
KFIN Technologies Results Update
KFin Technologies reported Q2FY27 revenue of ₹4,018.0 million, up 29.9% y-o-y, with PAT of ₹1,003.4 million. The figures come from a press release, not the full SEBI results statement.
KFIN Technologies Q2 FY27 Results: Net Profit ₹100.3 Cr, Up 7.5% YoY
KFIN Technologies Ltd reported revenue from operations of ₹401.8 Cr (+29.9% YoY) and net profit of ₹100.3 Cr (+7.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹100.3 Cr · +7.5% YoY
KFIN Technologies Other Announcement
KFin Technologies Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory compliance.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date